What are the typical presentations of G6PD (Glucose-6-Phosphate Dehydrogenase) deficiency?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Typical Presentations of G6PD Deficiency

G6PD deficiency typically presents with acute hemolytic anemia characterized by pallor, dark red urine, and jaundice occurring 24-72 hours after exposure to oxidative stressors such as certain foods (especially fava beans), medications, or infections. 1, 2

Clinical Manifestations

Acute Hemolytic Episodes

  • Primary manifestations:

    • Pallor (100% of cases) 2
    • Dark red/cola-colored urine (89.6% of cases) 2
    • Jaundice (87.8% of cases) 2
    • Fatigue and weakness
    • Abdominal or back pain
    • Shortness of breath
  • Laboratory findings during hemolysis:

    • Normocytic normochromic anemia
    • Reticulocytosis
    • Presence of Heinz bodies in red blood cells
    • Elevated indirect bilirubin
    • Decreased haptoglobin
    • Hemoglobinuria

Common Triggers of Hemolysis

  1. Dietary triggers (most common - 83.4% of cases) 2:

    • Fava beans (32.6%)
    • Falafel (19.4%)
    • Other legumes: chickpeas (10.8%), broad beans (7.6%), green peas (4.4%)
  2. Infections (12.4% of cases) 2:

    • Pneumonia (3.4%)
    • Tonsillitis (3.2%)
    • Typhoid fever (2.8%)
    • Hepatitis A (1.8%)
    • Urinary tract infections (1.2%)
  3. Medications (4.2% of cases) 2:

    • NSAIDs: diclofenac (2.4%), ibuprofen (0.8%), aspirin (0.4%)
    • Antimicrobials: co-trimoxazole (0.4%), nitrofurantoin (0.2%)
    • Other high-risk medications not to be used 1, 3:
      • Primaquine
      • Dapsone
      • Rasburicase
      • Methylene blue
      • Sulfonamides

Special Population Presentations

Neonatal Presentation

  • Neonatal jaundice: Can be severe and lead to kernicterus if not promptly treated 4
  • Hyperbilirubinemia may develop rapidly in the first week of life
  • Can occur in both males and females, though more common in males

Chronic Nonspherocytic Hemolytic Anemia

  • Rare presentation seen with certain G6PD mutations 5
  • Characterized by chronic hemolysis without exposure to known triggers
  • May present with chronic anemia, splenomegaly, and gallstones

Infection Susceptibility

  • Severe G6PD deficiency can lead to impaired neutrophil function 6
  • May present with recurrent bacterial infections similar to chronic granulomatous disease
  • Impaired neutrophil extracellular trap (NET) formation

Demographic Patterns

  • Gender distribution: Males are more commonly affected (93.2% males vs 6.8% females in large studies) 2
  • Age at first presentation: Most commonly between 1-3 years of age (92% of cases) 2
  • Geographic distribution: Highest prevalence in Africa, Mediterranean region, Middle East, Southeast Asia, and Oceania 3, 5

Severity Spectrum

  • Mild to moderate deficiency: Hemolysis typically occurs only with significant oxidative stress
  • Severe deficiency: May present with chronic hemolytic anemia or more frequent/severe hemolytic episodes
  • Enzyme activity correlation: Most common G6PD enzyme level during acute episodes is 3-4 U/gm Hb (59.2% of cases) 2

Clinical Pearls and Pitfalls

  • Hemolysis typically occurs 24-72 hours after exposure to triggers (average 36 hours) 2
  • Female carriers (heterozygotes) can also experience hemolysis due to random X-chromosome inactivation 1
  • Medications like amoxicillin, though generally considered safe, have rarely been reported to trigger hemolysis in G6PD-deficient individuals 7
  • The FDA label for primaquine specifically warns about the risk of hemolytic anemia in G6PD-deficient patients and recommends G6PD testing before administration 3

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.